An integrated multi-omics analysis identifies clinically relevant molecular subtypes of non-muscle-invasive bladder cancer
Sia V. Lindskrog(Aarhus University), Lars Dyrskjøt(Aarhus University Hospital), Karin Birkenkamp‐Demtröder(Aarhus University Hospital), Roman Nawroth(TUM Klinikum), Joshua J. Meeks(Northwestern University), Richard T. Bryan(Cancer Research UK Clinical Trials Unit), Frederik Prip(Aarhus University), Philippe Lamy(Aarhus University Hospital), Carolyn D. Hurst(University of Leeds), Marcus Horstmann(Friedrich Schiller University Jena), Lasse Maretty(Novo Nordisk (Denmark)), Douglas G. Ward(University of Birmingham), Dejan Dragičević(University of Belgrade), Tobias Maurer(Universität Hamburg), Mattias Höglund(Lund University), Núria Malats(Spanish National Cancer Research Centre), Ellen C. Zwarthoff(Erasmus MC), Iver Nordentoft(Aarhus University Hospital), Per‐Uno Malmström(Uppsala University), Aurélien de Reyniès(La Ligue Contre le Cancer), Trine Strandgaard(Aarhus University), Brian J. Jordan(University of Georgia), Emil Christensen(Aarhus University Hospital), Astrid Petersen(Aalborg University Hospital), Torben Steiniche(Aarhus University), Mateo Sokač(Aarhus University), Kim E.M. van Kessel(Erasmus University Rotterdam), Gregers G. Hermann(Frederiksberg Hospital), Francisco X. Real(Universitat Pompeu Fabra), David J. DeGraff(Penn State Milton S. Hershey Medical Center), Margaret A. Knowles(St James's University Hospital), Karin Mogensen(Frederiksberg Hospital), Gottfrid Sjödahl(Lund University), Veronika Weyerer(Friedrich-Alexander-Universität Erlangen-Nürnberg), Ulrika Segersten(Uppsala University), Nicolai J. Birkbak(Brigham and Women's Hospital), Joshua I. Warrick(Penn State Milton S. Hershey Medical Center), Xiaoqi Lin(Marine Biology Institute of Shandong Province), Danijel Sikic(Friedrich-Alexander-Universität Erlangen-Nürnberg), Jørgen Bjerggaard Jensen(University Psychiatric Hospital), Ann Taber(Aarhus University), Jay D. Raman(Penn State Milton S. Hershey Medical Center), Clarice S. Groeneveld(Universidade Federal do Paraná), Arndt Hartmann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Marc‐Oliver Grimm(Klinik und Poliklinik für Urologie), Anshita Goel(University of Birmingham), Tatjana Simić(University of Belgrade)
Cited by 10
Related Papers
The chromatin accessibility landscape of primary human cancers
|Science|2018|1.3k
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
|JAMA Oncology|2019|992
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Intragenic ERBB2 kinase mutations in tumours
|Nature|2004|790
Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
|Cancer Discovery|2012|684